Kangmei Pharmaceutical Co Ltd (600518) — Capital Reinvestment Ratio
Kangmei Pharmaceutical Co Ltd (600518) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥219.96 Million) in capital expenditures (CN¥48.57 Million). Check 600518 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kangmei Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2021)
This chart tracks Kangmei Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see 600518 operating cash flow.
Annual Capital Reinvestment Ratio for Kangmei Pharmaceutical Co Ltd (1999–2021)
Year-by-year Capital Reinvestment Ratio for Kangmei Pharmaceutical Co Ltd from 1999 to 2021. See Kangmei Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.80x | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥1.03 Billion | CN¥301.73 Million | ▲ +78.2% |
| 2019 | 0.16x | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.9% |
| 2018 | 15.03x | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1437.2% |
| 2016 | 0.98x | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.70x | CN¥508.86 Million | CN¥1.37 Billion | ▲ +348.5% |
| 2014 | 0.60x | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥30.25 Million | CN¥12.96 Million | — |